|
BRD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.041640E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.139400E-03 |
| Normal-vs-Stage2 |
5.943600E-01 |
| Normal-vs-Stage3 |
9.298800E-01 |
| Normal-vs-Stage4 |
7.519600E-01 |
| Stage1-vs-Stage2 |
1.619590E-01 |
| Stage1-vs-Stage3 |
4.277400E-03 |
| Stage1-vs-Stage4 |
5.344400E-03 |
| Stage2-vs-Stage3 |
5.350600E-01 |
| Stage2-vs-Stage4 |
4.565400E-01 |
| Stage3-vs-Stage4 |
8.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.987200E-01 |
| Normal-vs-AfricanAmerican |
7.554600E-04 |
| Normal-vs-Asian |
7.061000E-03 |
| Caucasian-vs-AfricanAmerican |
1.500530E-03 |
| Caucasian-vs-Asian |
5.119800E-02 |
| AfricanAmerican-vs-Asian |
8.517600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.815600E-01 |
| Normal-vs-Female |
7.400200E-04 |
| Male-vs-Female |
6.41019999999548E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.499400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.814340E-02 |
| Normal-vs-Age(61-80Yrs) |
3.766200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.913200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.536400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.821800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.468000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.093800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.882000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.024600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.41779999962566E-08 |
| Normal-vs-Grade 2 |
1.180430E-03 |
| Normal-vs-Grade 3 |
8.953200E-01 |
| Normal-vs-Grade 4 |
1.282220E-01 |
| Grade 1-vs-Grade 2 |
1.204680E-04 |
| Grade 1-vs-Grade 3 |
1.57130000011385E-07 |
| Grade 1-vs-Grade 4 |
4.55949999977889E-08 |
| Grade 2-vs-Grade 3 |
6.19179999999941E-05 |
| Grade 2-vs-Grade 4 |
3.70929999999881E-05 |
| Grade 3-vs-Grade 4 |
1.086600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.662200E-03 |
| Normal-vs-ccB subtype |
4.240400E-01 |
| ccA subtype-vs-ccB subtype |
2.3322999999964E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.187400E-01 |
| Normal-vs-N1 |
1.848020E-01 |
| N0-vs-N1 |
1.607810E-01 |
|
|
